Try our Advanced Search for more refined results
October 08, 2012
Avanir Pharmaceuticals Inc. v. Impax Laboratories Inc.
Case Number:
1:12-cv-01298
Court:
Nature of Suit:
Judge:
Unassigned Judge
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 09, 2012
Avanir Targets Impax Over Generic Nuedexta Plans
Avanir Pharmaceuticals Inc. on Monday sued rival Impax Laboratories Inc. in Delaware federal court, claiming Impax's plans to make a generic version of involuntary-emotion drug Nuedexta infringe one of its patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login